RxDoctor Payments Data

Kara Whalen, PA

Physician Assistant · Iowa City, IANPI 1518309301

Payments from drug & device makers

$523in general payments, 2019–2025

Across 23 payments — averaging $22.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$214
  • Baxter Healthcare$101
  • Otsuka America Pharmaceutical, Inc.$45
  • Dilon Technologies, Inc.$34
  • Axsome Therapeutics, Inc.$22
  • Corium, LLC$22
  • plus $85 from 5 others

What the payments were for

  • Food & beverage$523100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$523 in reported general payments places this provider in the 75th percentile of 1,140 physician assistant providers in Iowa.

See all physician assistant providers in Iowa

Medicare billing

Part B allowed, 2024
$1,383
Medicare patients
18
Services billed
18

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate12$20,386
Chlorpromazine Hcl23$8,691
Aripiprazole53$7,271
Clozapine76$3,469
Quetiapine Fumarate81$2,123
Olanzapine74$2,058
Desmopressin Acetate29$1,962
Divalproex Sodium ErDivalproex Sodium44$1,927
Desvenlafaxine Succinate ErDesvenlafaxine Succinate18$1,504
Sertraline Hcl151$1,201
Trazodone Hcl139$967
Fluvoxamine Maleate19$961
Guanfacine Hcl31$886
Propranolol Hcl31$757
Bupropion XlBupropion Hcl22$642

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$214$20,38612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,140 physician assistant providers in Iowa.

Other physician assistant in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →